Evidence map›Paper›PMID 32805343›Full record

ReviewFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2020

The under-reported role of toxic substance exposures in the COVID-19 pandemic.

Ronald N Kostoff, Michael B Briggs, Alan L Porter, Antonio F Hernández, Mohammad Abdollahi, Michael Aschner, Aristidis Tsatsakis

Open access · greenAbstract readReview
In one paragraph

Review in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Modifiable contributing factors to COVID-19: A comprehensive review.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Thrombosis and Haemostasis challenges in COVID-19 - Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini review.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Review
  16. Article
  17. [Comment] COVID‑19 vaccine safety.International journal of molecular medicine · 2020
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 5 countries.

Ronald N KostoffResearch Affiliate, School of Public Policy, Georgia Institute of Technology, Gainesville, VA, USA. Electronic address: rkostoff@gmail.com.
Michael B BriggsRoscommon, MI, USA.
Alan L PorterSchool of Public Policy, Georgia Institute of Technology, Atlanta, GA, USA; Search Technology, Peachtree Corners, GA, USA.
Antonio F HernándezDepartment of Legal Medicine and Toxicology, University of Granada School of Medicine, Health Sciences Technological Park, Granada, Spain.
Mohammad AbdollahiDepartment of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY, USA; IM Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Aristidis TsatsakisIM Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Laboratory of Toxicolgy and Forensic Sciences, Faculty of Medicine, University of Crete, 71003, Heraklion, Greece.
Georgia Institute of Technology · USAlbert Einstein College of Medicine · USTehran University of Medical Sciences · IRUniversidad de Granada · ESUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) and previous pandemics have been viewed almost exclusively as virology problems, with toxicology problems mostly being ignored. This perspective is not supported by the evolution of COVID-19, where the impact of real-life exposures to multiple toxic stressors degrading the immune system is followed by the SARS-CoV-2 virus exploiting the degraded immune system to trigger a chain of events ultimately leading to COVID-19. This immune system degradation from multiple toxic stressors (chemical, physical, biological, psychosocial stressors) means that attribution of serious consequences from COVID-19 should be made to the virus-toxic stressors nexus, not to any of the nexus constituents in isolation. The leading toxic stressors (identified in this study as contributing to COVID-19) are pervasive, contributing to myriad chronic diseases as well as immune system degradation. They increase the likelihood for comorbidities and mortality associated with COVID-19. For the short-term, tactical/reactive virology-focused treatments are of higher priority than strategic/proactive toxicology-focused treatments, although both could be implemented in parallel to reinforce each other. However, for long-term pandemic prevention, toxicology-based approaches should be given higher priority than virology-based approaches. Since current COVID-19 treatments globally ignore the toxicology component almost completely, only limited benefits can be expected from these treatments.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19Hazardous SubstancesHealthy LifestyleHumansPandemicsPneumonia, ViralQuarantineSARS-CoV-2Hazardous SubstancesContributing factorsCOVID-19Immune systemPandemicSARS-CoV-2Toxic mixture

Identifiers

PMID32805343
PMCPMC7426727
OpenAlexW3048453249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.